20 Years of Growth Hormone May Have Fueled Bone Spurs That Blocked Swallowing
A 62-year-old bodybuilder's chronic GH use is linked to a C3-C4 osteophyte compressing his esophagus — raising a novel hypothesis about anabolic hormones and bone overgrowth.
Summary
A 62-year-old ex-military bodybuilder presented with neck pain and, on directed questioning, disclosed intermittent swallowing difficulty. Imaging revealed a prominent anterior bone spur at cervical level C3-C4 compressing the esophagus, alongside severe multilevel cervical degeneration. The patient also reported approximately 20 years of exogenous growth hormone (GH) and GH secretagogue use — including cyclical somatropin and sermorelin/GHRP-6 — plus a prior jiu-jitsu neck injury. Authors hypothesize that chronic GH/IGF-1 axis stimulation, combined with remote trauma, may have accelerated osteophyte growth. Conservative management was initiated, and GH cessation was recommended. No causal link can be confirmed from a single case, but the report urges clinicians to screen for dysphagia in cervical spondylosis and to ask about anabolic substance use.
Detailed Summary
Anterior cervical osteophytes (ACOs) — bony spurs on the front of the vertebral bodies — affect an estimated 20–30% of adults over 60, yet symptomatic dysphagia from esophageal compression remains underdiagnosed. The C3-C6 region is particularly vulnerable because the hypopharynx transitions to the cervical esophagus there, with the esophagus lying in direct apposition to the prevertebral fascia. Most ACO literature focuses on age-related spondylosis or diffuse idiopathic skeletal hyperostosis (DISH); the potential contribution of systemic anabolic factors has rarely been explored.
The patient was a 62-year-old ex-military recreational bodybuilder who presented in January 2025 with cervicalgia and left shoulder pain. His past history included hypertension, lumbar radiculopathy, glenohumeral and acromioclavicular osteoarthritis, rotator cuff tendinitis, and a prior proximal biceps tendon rupture. He reported a cervical hyperextension/hyperflexion injury during Brazilian jiu-jitsu training around 2001–2002. Crucially, he also self-reported approximately 20 years of GH axis stimulation: cyclical somatropin (~2005–2016, 0.4 mg SC up to twice daily), followed by sermorelin plus GHRP-6 (~2016–2019+), and ongoing nightly somatropin at presentation. None of this exposure history was verified through pharmacy records, prescriptions, or laboratory IGF-1 data.
Cervical radiographs showed loss of lordosis, multilevel facet hypertrophy, disc narrowing, and a prominent C3-C4 anterior osteophyte. MRI confirmed esophageal compression at C3-C4, plus moderate-to-severe central canal stenosis at C2-C4 and severe stenosis at C4-C7. On directed questioning, the patient admitted to intermittent dysphagia with large food boluses — a symptom he had not previously volunteered. Symptoms were mild and intermittent without aspiration, weight loss, or dietary restriction. A September 2025 chest x-ray later revealed multiple bony projections along the sternum and diffuse thoracic degenerative changes, raising the possibility of systemic hyperostosis consistent with DISH, though formal Resnick criteria were not applied.
The authors propose a two-hit hypothesis: remote cervical trauma disrupted the anterior longitudinal ligament and periosteum, priming the site for heterotopic bone formation, while decades of GH/IGF-1 axis stimulation — which drives chondrocyte proliferation, endochondral ossification, and periosteal apposition, mirroring the skeletal arthropathy of acromegaly — may have amplified osteophyte growth beyond what aging alone would produce. Conservative management (dietary modification, NSAIDs as needed, home exercise) was initiated; surgical osteophytectomy via an anterior cervical approach was discussed as a future option if symptoms progress. GH cessation and endocrine referral were recommended.
This case is hypothesis-generating rather than confirmatory. Dysphagia was not formally evaluated with barium swallow or videofluoroscopic swallowing study. GH exposure is entirely self-reported. Myelopathy assessment was incomplete despite severe multilevel stenosis. And the skeletal findings could plausibly be explained by age-related spondylosis or DISH alone. Nevertheless, the report makes a clinically important point: patients with cervical spondylosis should be actively screened for dysphagia, and clinicians should routinely inquire about anabolic hormone use as part of the musculoskeletal history.
Key Findings
- C3-C4 anterior osteophyte caused esophageal compression and intermittent dysphagia, only disclosed after directed questioning.
- Patient self-reported ~20 years of cyclical somatropin and GH secretagogue (sermorelin/GHRP-6) use prior to presentation.
- Chest x-ray showed sternal bony projections and thoracic hyperostosis, raising possibility of systemic DISH-like syndrome.
- Authors hypothesize combined remote cervical trauma and chronic GH/IGF-1 stimulation may synergistically drive exuberant osteophyte formation.
- Conservative management with dietary modification and GH cessation counseling was initiated; surgical osteophytectomy remains an option if symptoms progress.
Methodology
This is a single case report from an outpatient orthopedic and sports medicine clinic. Diagnosis relied on lateral cervical radiography and MRI without contrast; no formal swallowing study (barium swallow or VFSS) or verified laboratory data (IGF-1 levels) was obtained. GH exposure history is entirely patient-reported and unverified.
Study Limitations
The GH exposure history is entirely self-reported with no pharmacy records, prescriptions, or contemporaneous IGF-1 measurements to verify dose or duration. No objective swallowing evaluation (barium swallow or VFSS) was performed, and a comprehensive myelopathy examination was incomplete despite severe multilevel stenosis on MRI. Causal inference is impossible from a single case; observed skeletal changes could reflect age-related spondylosis, DISH, or post-traumatic remodeling independent of GH use.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
